Zibotentan, an Endothelin A Receptor Antagonist, Prevents Amyloid-ß-Induced Hypertension and Maintains Cerebral Perfusion. (2020)
Attributed to:
MICA: ET-1-mediated reduction of cerebral blood flow in Alzheimer's disease: therapeutic potential of zibotentan
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3233/jad-190630
PubMed Identifier: 31903990
Publication URI: http://europepmc.org/abstract/MED/31903990
Type: Journal Article/Review
Volume: 73
Parent Publication: Journal of Alzheimer's disease : JAD
Issue: 3
ISSN: 1387-2877